Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

HLA Protein Technologies Announces Next-Gen HLA Product Lines and Strategic Investment

News Source: HLA Protein Technologies Inc.

OKLAHOMA CITY, Okla., Sept. 30, 2025 (SEND2PRESS NEWSWIRE) — HLA Protein Technologies, Inc. (formerly Pure Protein, LLC) reports that its new manufacturing expansion is positioned to support the Company’s growth. A new product line launch, a strategic investment led by a private investor group; and a corporate rebrand to HLA Protein Technologies, reflects the company’s expanded focus on advanced immunology and oncology research tools.

HLA Protein Technologies, Inc. (formerly Pure Protein, LLC)
Image caption: HLA Protein Technologies, Inc.

The new investment will fund accelerated product development and expanded manufacturing capacity at the company’s Oklahoma City headquarters, with additional hiring across R&D, bioprocess and commercial operations. HLA Protein Technologies will scale production capacity, implement expanded QC/QA frameworks and enhance GMP‑adjacent processes suitable for research‑use‑only (RUO) products.

The company expects to add roles across protein biochemistry, cell biology, manufacturing operations and commercial support. Facility enhancements will prioritize throughput, reproducibility and documentation standards to align with customer expectations in biopharma R&D.

And, the rebrand to HLA Protein Technologies unifies the company’s legacy of protein engineering with its expanded mission: delivering best‑in‑class HLA research tools and services to customers across biopharma, diagnostics and translational research. This transition establishes a brand identity that mirrors the company’s core scientific strengths and customer value proposition in HLA‑based research tools. The new name and visual identity will roll out across product labels, documentation and digital properties over the coming weeks.

“This is a pivotal moment in our company’s evolution,” said Dr. Rico Buchli, Chief Scientist at HLA Protein Technologies. “Our new HLA portfolio pairs rigorously characterized reagents with custom services that help biopharma teams accelerate target discovery and validation, immune monitoring and mechanism‑of‑action studies. The rebrand reflects our commitment to leadership in HLA‑enabled solutions.”

Anchored by two decades of expertise in soluble HLA engineering and peptide–MHC technologies, the new product lines will feature next‑generation Class I and Class II HLA tetramers, new product formats and custom peptide‑loaded complexes designed for high‑throughput discovery, screening and translational studies.

This portfolio will be complemented by custom assay development and engineered cell line services to support biopharma and academic partners advancing immunotherapies and vaccine research. These new products will complement the Company’s existing portfolio of more than 275 HLA Class I and Class II alleles; it will be made available to the scientific community at https://hlaprotein.com/.

“Oklahoma’s life sciences ecosystem is gaining momentum, and HLA Protein Technologies’ growth exemplifies that trajectory,” said Michelle Gregory, Director, Life Science Oklahoma. “The company’s expansion and investment in local manufacturing aligns with our mission to advance U.S.-based innovation and bioproduction.”

About HLA Protein Technologies, Inc.

HLA Protein Technologies, Inc., based in Oklahoma City, Oklahoma, specializes in high‑purity HLA proteins, engineered cell lines and custom assay development. With a focus on immunology and oncology, the company provides HLA‑based reagents and services that enable discovery, lead validation and translational research. HLA Protein Technologies serves leading pharma, diagnostic and research customers in more than 20 countries.

Public and media queries: https://www.hlaprotein.com/contact-us

MULTIMEDIA:

Logo link for media: https://www.Send2Press.com/300dpi/25-0930-s2p-hlaprot-300dpi.webp


This press release was issued on behalf of the news source (HLA Protein Technologies Inc.), who is solely responsible for its accuracy, by Send2Press Newswire.

To view the original story, visit: https://www.send2press.com/wire/hla-protein-technologies-announces-next-gen-hla-product-lines-and-strategic-investment/

Copr. © 2025 Send2Press® Newswire, Calif., USA. -- REF: S2P STORY ID: S2P129731 FCN24-3B

 

INFORMATION BELOW THIS PAGE, IF ANY, IS UNRELATED TO THIS PRESS RELEASE.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.